Sri Yuva Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-05-2024
- Paid Up Capital ₹ 0.10 M
as on 28-05-2024
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 33.54%
(FY 2022)
- Profit 10.48%
(FY 2022)
- Ebitda 13.33%
(FY 2022)
- Net Worth 21.53%
(FY 2022)
- Total Assets 14.56%
(FY 2022)
About Sri Yuva Biotech
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Narendra Papathoti and Srilatha Bathula serve as directors at the Company.
- CIN/LLPIN
U74995TG2017PTC120013
- Company No.
120013
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sri Yuva Biotech Private Limited offer?
Sri Yuva Biotech Private Limited offers a wide range of products and services, including Medical Educational Service, Biotechnology Courses, Fertilizer, Organic Fertilizers and Manure, Bio Fertilizers, Industrial Chemicals, Animal Feed Supplement, Feed Supplement, Insecticides, Biopesticides.
Who are the key members and board of directors at Sri Yuva Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narendra Papathoti  | Director | 20-Sep-2022 | Current |
| Srilatha Bathula | Director | 22-Apr-2018 | Current |
Financial Performance of Sri Yuva Biotech.
Sri Yuva Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.54% increase. The company also saw a substantial improvement in profitability, with a 10.48% increase in profit. The company's net worth Soared by an impressive increase of 21.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Yuva Biotech?
Unlock access to Sri Yuva Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Srigpavens Life Sciences Private LimitedActive 2 years 2 monthsNarendra Papathoti is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sri Yuva Biotech?
Unlock and access historical data on people associated with Sri Yuva Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Yuva Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Yuva Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
